Center for Data-driven Insights and Innovation (CDI2)

The Center for Data-driven Insights and Innovation (CDI2) was established in January 2018.

CDI2 oversees the University of California Health Data Warehouse (UCHDW), a unique data asset created by electronic health records (EHR) from our six health centers as well as claims data from UC’s self-funded health plans and external sources of data such as Vizient and California's Office of Statewide Health Planning and Development (OSHPD).

UCHDW currently holds modern data on over six million patients seen at a UC facility since 2012. These patients received care from nearly 150,000 health care providers in over 200 million encounters, with over 600 million diagnosis records, with over 400 million procedures, more than 600 million medication records, and with over two billion vital signs measurements and test results. Over 650,000 of these patients are primary care patients.

UCH uses clinical data in a safe, respectful way to optimally treat patients with key diseases and conditions. One example is the UC Cancer Consortium, comprised of the five National Cancer Institute designed (NCI-designated) Comprehensive Cancer Centers within the UC system. To ensure appropriate use of the data, CDI2 convenes a Health Data Governance Committee and a 'tiger team' of experts to evaluate data use proposals.

Current activities include, but are not limited to:

  • Population Health initiatives for UC Care, a self-funded PPO option offered to UC employees. CDI2 is helping transform efforts in utilization management, providing the ability to measure outcomes that define operational success. Campus population health leaders can now directly compare costs and utilization across UCH.
  • Value-based Metrics, such as the Quality Incentive Program (QIP), a new pay-for-performance program for California hospitals serving Medi-Cal patients. CDI2 efforts, along with collaboration among all academic health centers, enabled the work load to be shared and positioned the entire system for the shift to value-based metrics.
  • Pharmacy Initiatives, enabling a system-wide pharmacy work group to identify areas of opportunity in the self-funded plan drug spend. Analyses included comparator lists of brand and generic drugs, system-wide trends for drugs prescribed as “dispense as written,” and data for UC Care patients’ diabetes treatment pathways. In 2018, this initial work started with four specific drugs in the areas of diabetes, cardiovascular disease, and psychiatry.

For questions or for more information, please email